Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine

计划入组 6,080 人 · 首次发布于 2024 年 2 月 28 日

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

首次发布于 2020 年 11 月 2 日

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

计划入组 1,200 人 · 首次发布于 2023 年 3 月 28 日

live-attenuated SARS-CoV-2 viral vaccine

SARS-CoV-2 vaccine

SARS-CoV-2 mRNA vaccine

Invivyd

United States

Vaxart

United States

Arbutus Biopharma

United States

Emergent BioSolutions Invests in Rocketvax to Advance Next-Generation Vaccine Development

NIH Launches Phase 1 Trial of Nasal COVID-19 Vaccine MPV/S-2P

Intranasal COVID-19 Vaccine CDO-7N-1 Advances to Clinical Trials